MedTrace Logo

The Role of Multislice Computed Tomography in Congenital Heart Diseases in Paediatric Age Group.

NCT06223321 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-01-25

No results posted yet for this study

Summary

This study aims to evaluate the added value of cardiac multislice Computed Tomography in assessment of CHD in pediatrics as a non-invasive presurgical planning method

Conditions

  • Congenital Heart Diseases

Interventions

DIAGNOSTIC_TEST

Computed Tomography in congenital heart diseases

● CT examination will be done by * 160 MDCT Toshiba Machine or 128 MDCT GE machine or 160 MDCT Philips Machine: * We used the following parameters during cardiac CT scanning: * Pitch of 1.3, helical thickness of 0.5 mm and coverage of 32 cm. * The radiation dose set to 80-100 kvp. * Tube current from 10 to 40 mA/kg. * The gantry rotation speed at 0.35-.4 sec. * ECG gated Retrospective With MA modulation. * Wide FOV. * A scout will be taken and dual-phase injection conducted using non ionized contrast material. The total contrast volume is 1.5-3 ml/kg. * Scanning begins when contrast filled the LV by bolus tracking. * All images were transferred to workstation multiplanar reformation (MPR), maximum (MIP) and minimum (MinIP) intensity projections and volume rendering images will be performed for reporting.

Sponsors & Collaborators

  • Magdi Yacoub Heart Foundation

    collaborator OTHER

  • Sohag University

    lead OTHER

Principal Investigators

  • Mohamed AA Elsherif, ASSISST. LEC · Sohag University Hospitals

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-03
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06223321 on ClinicalTrials.gov